Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy (vol 3, pg 283, 2019)

被引:0
|
作者
Helbling, D. C.
机构
关键词
D O I
10.1093/jnen/nlz035
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:932 / 932
页数:1
相关论文
共 28 条
  • [21] Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019)
    Montalto, Claudio
    Mangieri, Antonio
    Jabbour, Richard J.
    Pagnesi, Matteo
    Buzzatti, Nicola
    Leone, Pierpasquale
    Regazzoli, Damiano
    Ancona, Francesco
    Lanzillo, Giuseppe
    Giannini, Francesco
    Stella, Stefano
    De Bonis, Michele
    Alfieri, Ottavio
    Camici, Paolo G.
    Margonato, Alberto
    Colombo, Antonio
    Agricola, Eustachio
    Latib, Azeem
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2020, 4 (06): : W535 - W535
  • [22] Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride (vol 9, 3807, 2019)
    Takizawa, Hotake
    Hara, Yuko
    Mizobe, Yoshitaka
    Ohno, Taisuke
    Suzuki, Sadafumi
    Inoue, Ken
    Takeshita, Eri
    Shimizu-Motohashi, Yuko
    Ishiyama, Akihiko
    Hoshino, Mikio
    Komaki, Hirofumi
    Takeda, Shin'ichi
    Aoki, Yoshitsugu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] RETRACTION: TREM-1 Attenuates RIPK3-mediated Necroptosis in Hyperoxia-induced Lung Injury in Neonatal Mice (Retraction of Vol 60, Pg 308, 2019)
    Syed, M. A.
    Shah, D.
    Das, P.
    Andersson, S.
    Pryhuber, G.
    Bhandari, V.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 64 (04) : 518 - 518
  • [24] Long-term safety and efficacy of benralizumab in patients with severe, un-controlled asthma: 1-year results from the BORA phase 3 extension trial (vol 7, pg 46, 2019)
    Busse, W. W.
    Bleecker, E. R.
    FitzGerald, J. M.
    LANCET RESPIRATORY MEDICINE, 2019, 7 (01): : E1 - E1
  • [25] 85th ENMC International Workshop on Congenital Muscular Dystrophy - 6th International CMD Workshop - 1st Workshop of the Myo-Cluster Project 'GENRE' - 27-28th October 2000, Naarden, The Netherlands (vol 12, pg 69, 2002)
    Muntoni, F
    Blake, D
    Brockington, M
    Brown, S
    Hayashi, YK
    Merlini, L
    Sabatelli, P
    Topaloglu, H
    Voit, T
    Guicheney, P
    NEUROMUSCULAR DISORDERS, 2002, 12 (04) : COVER4 - COVER4
  • [26] RETRACTION: The Inhibitive Effect of sh-HIF1A-AS2 on the Proliferation, Invasion, and Pathological Damage of Breast Cancer via Targeting miR-548c-3p Through Regulating HIF-1α/VEGF Pathway in vitro and vivo (Retraction of Vol 12, Pg 825, 2019)
    Guo, X.
    Lee, S.
    Cao, P.
    ONCOTARGETS AND THERAPY, 2021, 14 : 1003 - 1003
  • [27] RETRACTION: microRNA-129-5p involved in the neuroprotective effect of dexmedetomidine on hypoxic-ischemic brain injury by targeting COL3A1 through the Wnt/β-catenin signaling pathway in neonatal rats (Retraction of Vol 120, Pg 6908, 2019)
    Zhou, Xiu-Min
    Liu, Jie
    Wang, Ying
    Zhang, Shu-Li
    Zhao, Xin
    Xu, Xiang
    Pei, Jian
    Zhang, Man-He
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S92 - S92
  • [28] The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant (vol 21, pg 676, 2019)
    Rutten, Julie W.
    Van Eijsden, Bastian J.
    Duering, Marco
    Jouvent, Eric
    Opherk, Christian
    Pantoni, Leonardo
    Federico, Antonio
    Dichgans, Martin
    Markus, Hugh S.
    Chabriat, Hugues
    Oberstein, Saskia A. J. Lesnik
    GENETICS IN MEDICINE, 2019, 21 (08) : 1895 - 1895